Research and experimental development on natural sciences and engineering
KLYV THERAPEUTICS AS
Revenue 2024
NOK 935,000
Operating profit
NOK 161,000
Equity
NOK 718,000
Incorporated
2023
Share capital
NOK 122,000
Key figures · 2024
Current ratio
4.31
Equity ratio
76.8%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 17.3% | |
| Net margin (%%) | 13.2% | |
| Return on assets (%%) | 17.3% | |
| Likviditet | ||
| Current ratio | 4.31 | |
| Working capital | 718k | |
| Soliditet | ||
| Equity ratio (%%) | 76.8% | |
| Debt-to-equity ratio | 0.30 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.